Synchronous hepatocellular carcinoma and renal cell carcinoma: A cytological marvel.
FNAC
hepatocellular carcinoma
multiple primary malignancy
renal cell carcinoma
synchronous
Journal
Diagnostic cytopathology
ISSN: 1097-0339
Titre abrégé: Diagn Cytopathol
Pays: United States
ID NLM: 8506895
Informations de publication
Date de publication:
13 Feb 2024
13 Feb 2024
Historique:
revised:
30
01
2024
received:
11
10
2023
accepted:
31
01
2024
medline:
14
2
2024
pubmed:
14
2
2024
entrez:
14
2
2024
Statut:
aheadofprint
Résumé
Multiple primary synchronous tumours have always created an inquisitiveness among clinicians, radiologists and pathologists. The diagnosis invariably proposes a challenge to diagnosticians. The coexistence of a primary hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC) is exceedingly rare, with countable number of cases being reported in literature. We report a pioneer case of 75-year-old male, having chronic hepatitis B, diagnosed with synchronous primary RCC and HCC in by fine-needle aspiration cytology (FNAC) and confirmed by immunohistochemistry.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Wong LL, Lurie F, Takanishi DM Jr. Other primary neoplasms in patients with hepatocellular cancer: prognostic implications? Hawaii Med J. 2007;66:206-208.
Can A, Dogan E, Bayoglu IV, et al. Multicenter epidemiologic study on hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev. 2014;15:2923-2927.
Akkiz H, Carr BI, Kendal YK, et al. Characteristics of hepatocellular carcinoma aggressiveness factors in Turkish patients. Oncology. 2018;94:116-124.
Tomas K, Oguz S, Topaloglu S, et al. Is it rational to perform liver resection for patients with intermediate and advanced stages of hepatocellular carcinoma? Am Surg. 2020;86:313-323.
Shetty GS, Bhalla P, Desai SM, Wagle PK, Mehta HS. Synchronous hepatocellular carcinoma with renal cell carcinoma: a case report and review of literature of multiple synchronous primary malignancies. Indian J Surg. 2013;75:290-292.
Lee YS, Kim JH, Yoon HY, Choe WH, Kwon SY, Lee CH. A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation. Clin Mol Hepatol. 2014;20:306-309.
Gang G, Hongkai Y, Xu Z. Sorafenib combined with radiofrequency ablation in the treatment of a patient with renal cell carcinoma plus primary hepatocellular carcinoma. J Cancer Res Ther. 2015;11:10-26.
Zhang W, Wang Q, Jiang YX, et al. Simultaneous double primary clear cell carcinomas of liver and kidney: a case report and review of literature. Int J Clin Exp Pathol. 2015;8:995-999.
Sun JJ, Yang TB, Yang YH, Liu WF, Song JX. Synchronous double primary malignancies of the liver and kidney: a case report. Oncol Lett. 2016;11:2057-2060.
Hou S, Wang L, Qi S. Synchronous hepatocellular carcinoma with renal cell carcinoma: a case report and review of literature. Int J Clin Exp Med. 2017;10:11026-11032.
Prejac J, Kekez D, Belev B, Kocić L, Bulimbašić S, Pleština S. Leukocytoclasticvasculitis associated with sorafenib treatment for hepatocellular carcinoma. Anti-Cancer Drugs. 2020;31:76-77.
Bruix J, Reig M, Sherman M. Evidencebased diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150:835-853.
Eyuboglu K, Reis ME, Colak F, Topaloglu S, Cobanoglu U, Calik A. Synchronous occurrence of hepatocellular carcinoma and renal cell carcinoma: a case report. J Surg Res. 2022;5:229-237.
Kim KM, Sinn DH, Jung SH, et al. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients? Liver Int. 2016;36:1490-1497.